- Dabiclot 110 mg Tablet is primarily used for stroke prevention in patients with atrial fibrillation.
- This medication effectively treats deep vein thrombosis (DVT) and pulmonary embolism (PE).
- It helps prevent heart attacks by reducing the risk of blood clots.
- Dabiclot 110 mg Tablet is beneficial for patients undergoing certain surgeries to prevent postoperative clots.
- The formulation aids in managing anticoagulation therapy without the need for frequent monitoring.
- Dabiclot 110 mg Tablet is suitable for long-term use in patients with a history of thromboembolic events.
- This therapy is advantageous due to its predictable pharmacokinetics, allowing for fixed dosing.
- Patients using Dabiclot 110 mg Tablet experience fewer dietary restrictions compared to traditional anticoagulants.
Dabiclot 110 mg Tablet - Strip of 10
Compositions : Dabigatran Etexilate Mesilate 110mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Alkem Laboratories Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Dabiclot 110 mg Tablet is a specialized medication designed to prevent and treat blood clots. This formulation contains the active ingredient Dabigatran Etexilate, which is classified as a novel oral anticoagulant (NOAC). The primary purpose of Dabiclot 110 mg Tablet is to reduce the risk of stroke and other serious complications associated with blood clot formation. By inhibiting specific clotting factors in the blood, Dabiclot 110 mg Tablet effectively prevents the development of clots in various parts of the body, including the legs, lungs, brain, and heart. The key composition of Dabiclot 110 mg Tablet ensures that patients receive a reliable and effective treatment option for managing their anticoagulation needs. As a member of the therapeutic category of anticoagulants, Dabiclot 110 mg Tablet plays a crucial role in maintaining cardiovascular health and preventing life-threatening conditions. Patients prescribed Dabiclot 110 mg Tablet can trust its efficacy in managing their health conditions related to blood clotting disorders. The formulation is designed for easy administration, making it a convenient choice for those requiring long-term anticoagulation therapy. Overall, Dabiclot 110 mg Tablet is an essential medication for individuals at risk of thromboembolic events, providing peace of mind and improved quality of life.
Product Details
Dabiclot 110 mg Tablet works by inhibiting thrombin, a key enzyme in the coagulation cascade that leads to blood clot formation. This action effectively reduces the ability of the blood to clot, thereby preventing thromboembolic events.
- Dabigatran Etexilate, the active ingredient in Dabiclot 110 mg Tablet, is converted into its active form in the body.
- It directly inhibits thrombin, preventing fibrin formation and subsequent clot development.
- This mechanism allows for rapid onset of action, providing immediate anticoagulation effects.
- Dabiclot 110 mg Tablet does not require routine monitoring like other anticoagulants.
- The formulation has a predictable pharmacological profile, ensuring consistent therapeutic outcomes.
- By targeting specific pathways in the coagulation process, Dabiclot 110 mg Tablet minimizes the risk of bleeding complications.
- This medication is effective in both venous and arterial thromboembolic conditions.
- Dabiclot 110 mg Tablet should be taken exactly as prescribed by a healthcare professional.
- The recommended dosage typically starts at one tablet taken orally twice daily.
- It is advisable to take Dabiclot 110 mg Tablet at the same times each day to maintain consistent blood levels.
- The duration of treatment with Dabiclot 110 mg Tablet will depend on individual patient needs and medical advice.
- Patients should swallow the tablet whole with water; do not crush or chew it.
- Special instructions may include adjusting dosage based on kidney function or other health conditions.
- Consult a healthcare provider before stopping or altering the dosage of Dabiclot 110 mg Tablet.
- Maintain a balanced diet rich in fruits and vegetables to support overall health while on Dabiclot 110 mg Tablet.
- Avoid excessive alcohol consumption as it can increase bleeding risks associated with this medication.
- Engage in regular physical activity to promote circulation but avoid high-impact sports that could lead to injury.
- Stay hydrated to support kidney function while taking Dabiclot 110 mg Tablet.
- Monitor your health regularly and keep track of any unusual symptoms or side effects during treatment.
Safety Advice
Side Effects
- Common side effects of Dabiclot 110 mg Tablet include nausea and gastrointestinal discomfort.
- Some patients may experience dyspepsia or abdominal pain while taking this medication.
- There is a risk of bleeding; patients should monitor for signs such as unusual bruising or bleeding.
- Serious side effects may include severe gastrointestinal bleeding or anemia.
- If symptoms like blood in urine or stool occur, seek immediate medical attention.
- Consult a doctor if side effects persist or worsen over time while using Dabiclot 110 mg Tablet.
Precautions and Warnings
- Dabiclot 110 mg Tablet should not be used by individuals with active bleeding disorders or severe renal impairment.
- Patients should inform their healthcare provider about any history of bleeding issues before starting treatment.
- Pregnant or breastfeeding women should consult their doctor before using Dabiclot 110 mg Tablet.
- Avoid alcohol consumption while taking this medication due to increased bleeding risk.
- Regular monitoring may be necessary for patients with kidney problems during treatment with Dabiclot 110 mg Tablet.
- Inform your doctor about all medications being taken to avoid potential drug interactions.
- Patients should be cautious when engaging in activities that could lead to injury while on this therapy.
FAQs
Dabiclot 110 mg Tablet is primarily used for preventing strokes and treating conditions like deep vein thrombosis and pulmonary embolism.
2. How should I take Dabiclot 110 mg Tablet?
Dabiclot 110 mg Tablet should be taken as prescribed by your doctor, typically one tablet twice daily with water.
3. Are there any side effects associated with Dabiclot 110 mg Tablet?
Common side effects include nausea and gastrointestinal discomfort. Serious side effects may involve unusual bleeding.
4. Can I drink alcohol while taking Dabiclot 110 mg Tablet?
It is advisable to avoid alcohol consumption while taking Dabiclot 110 mg Tablet due to increased bleeding risks.
5. Who should avoid using Dabiclot 110 mg Tablet?
Individuals with active bleeding disorders or severe renal impairment should not use Dabiclot 110 mg Tablet.
6. What should I do if I miss a dose of Dabiclot 110 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not double up.
7. Is regular monitoring required while on Dabiclot 110 mg Tablet?
Unlike some other anticoagulants, regular lab tests are not typically required when taking Dabiclot 110 mg Tablet.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 4012 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Alkem Laboratories Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Dabiclot 110 mg Tablet is a specialized medication designed to prevent and treat blood clots. This formulation contains the active ingredient Dabigatran Etexilate, which is classified as a novel oral anticoagulant (NOAC). The primary purpose of Dabiclot 110 mg Tablet is to reduce the risk of stroke and other serious complications associated with blood clot formation. By inhibiting specific clotting factors in the blood, Dabiclot 110 mg Tablet effectively prevents the development of clots in various parts of the body, including the legs, lungs, brain, and heart. The key composition of Dabiclot 110 mg Tablet ensures that patients receive a reliable and effective treatment option for managing their anticoagulation needs. As a member of the therapeutic category of anticoagulants, Dabiclot 110 mg Tablet plays a crucial role in maintaining cardiovascular health and preventing life-threatening conditions. Patients prescribed Dabiclot 110 mg Tablet can trust its efficacy in managing their health conditions related to blood clotting disorders. The formulation is designed for easy administration, making it a convenient choice for those requiring long-term anticoagulation therapy. Overall, Dabiclot 110 mg Tablet is an essential medication for individuals at risk of thromboembolic events, providing peace of mind and improved quality of life.
- Dabiclot 110 mg Tablet is primarily used for stroke prevention in patients with atrial fibrillation.
- This medication effectively treats deep vein thrombosis (DVT) and pulmonary embolism (PE).
- It helps prevent heart attacks by reducing the risk of blood clots.
- Dabiclot 110 mg Tablet is beneficial for patients undergoing certain surgeries to prevent postoperative clots.
- The formulation aids in managing anticoagulation therapy without the need for frequent monitoring.
- Dabiclot 110 mg Tablet is suitable for long-term use in patients with a history of thromboembolic events.
- This therapy is advantageous due to its predictable pharmacokinetics, allowing for fixed dosing.
- Patients using Dabiclot 110 mg Tablet experience fewer dietary restrictions compared to traditional anticoagulants.
Dabiclot 110 mg Tablet works by inhibiting thrombin, a key enzyme in the coagulation cascade that leads to blood clot formation. This action effectively reduces the ability of the blood to clot, thereby preventing thromboembolic events.
- Dabigatran Etexilate, the active ingredient in Dabiclot 110 mg Tablet, is converted into its active form in the body.
- It directly inhibits thrombin, preventing fibrin formation and subsequent clot development.
- This mechanism allows for rapid onset of action, providing immediate anticoagulation effects.
- Dabiclot 110 mg Tablet does not require routine monitoring like other anticoagulants.
- The formulation has a predictable pharmacological profile, ensuring consistent therapeutic outcomes.
- By targeting specific pathways in the coagulation process, Dabiclot 110 mg Tablet minimizes the risk of bleeding complications.
- This medication is effective in both venous and arterial thromboembolic conditions.
- Dabiclot 110 mg Tablet should be taken exactly as prescribed by a healthcare professional.
- The recommended dosage typically starts at one tablet taken orally twice daily.
- It is advisable to take Dabiclot 110 mg Tablet at the same times each day to maintain consistent blood levels.
- The duration of treatment with Dabiclot 110 mg Tablet will depend on individual patient needs and medical advice.
- Patients should swallow the tablet whole with water; do not crush or chew it.
- Special instructions may include adjusting dosage based on kidney function or other health conditions.
- Consult a healthcare provider before stopping or altering the dosage of Dabiclot 110 mg Tablet.
- Maintain a balanced diet rich in fruits and vegetables to support overall health while on Dabiclot 110 mg Tablet.
- Avoid excessive alcohol consumption as it can increase bleeding risks associated with this medication.
- Engage in regular physical activity to promote circulation but avoid high-impact sports that could lead to injury.
- Stay hydrated to support kidney function while taking Dabiclot 110 mg Tablet.
- Monitor your health regularly and keep track of any unusual symptoms or side effects during treatment.
Side Effects
- Common side effects of Dabiclot 110 mg Tablet include nausea and gastrointestinal discomfort.
- Some patients may experience dyspepsia or abdominal pain while taking this medication.
- There is a risk of bleeding; patients should monitor for signs such as unusual bruising or bleeding.
- Serious side effects may include severe gastrointestinal bleeding or anemia.
- If symptoms like blood in urine or stool occur, seek immediate medical attention.
- Consult a doctor if side effects persist or worsen over time while using Dabiclot 110 mg Tablet.
Precautions and Warnings
- Dabiclot 110 mg Tablet should not be used by individuals with active bleeding disorders or severe renal impairment.
- Patients should inform their healthcare provider about any history of bleeding issues before starting treatment.
- Pregnant or breastfeeding women should consult their doctor before using Dabiclot 110 mg Tablet.
- Avoid alcohol consumption while taking this medication due to increased bleeding risk.
- Regular monitoring may be necessary for patients with kidney problems during treatment with Dabiclot 110 mg Tablet.
- Inform your doctor about all medications being taken to avoid potential drug interactions.
- Patients should be cautious when engaging in activities that could lead to injury while on this therapy.
Dabiclot 110 mg Tablet is primarily used for preventing strokes and treating conditions like deep vein thrombosis and pulmonary embolism.
2. How should I take Dabiclot 110 mg Tablet?
Dabiclot 110 mg Tablet should be taken as prescribed by your doctor, typically one tablet twice daily with water.
3. Are there any side effects associated with Dabiclot 110 mg Tablet?
Common side effects include nausea and gastrointestinal discomfort. Serious side effects may involve unusual bleeding.
4. Can I drink alcohol while taking Dabiclot 110 mg Tablet?
It is advisable to avoid alcohol consumption while taking Dabiclot 110 mg Tablet due to increased bleeding risks.
5. Who should avoid using Dabiclot 110 mg Tablet?
Individuals with active bleeding disorders or severe renal impairment should not use Dabiclot 110 mg Tablet.
6. What should I do if I miss a dose of Dabiclot 110 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not double up.
7. Is regular monitoring required while on Dabiclot 110 mg Tablet?
Unlike some other anticoagulants, regular lab tests are not typically required when taking Dabiclot 110 mg Tablet.
Directions for Use
Storage and Disposal
| SKU | 4012 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Alkem Laboratories Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account